Joint Statement on Proposals for the FY2025 Off-year Drug Price Revision and National Biopharmaceutical Strategy

Joint Statement on Proposals for the 2024 Drug Pricing Reform

JPMA, PhRMA and EFPIA: Joint Statement on FY2023 NHI Price Revisions